Vasovist News
Most Popular Vasovist Story
Epix shares soar on Vasovist approval
Epix Pharmaceuticals won the FDA's approval for the imaging agent Vasovist, and investors reacted by sending the company's battered stock price soaring. Epix shares added 85 cents, to $1.17. Epix Read more...
Latest Headlines
- December 23, 2008
- September 4, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
